For the quarter ending 2026-03-31, APYX made $12,490K in revenue. -$2,108K in net income. Net profit margin of -16.88%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Sales, net | 12,490 | 19,164 | 12,877 | 11,373 |
| Cost of sales | 4,565 | 7,165 | 4,580 | 4,290 |
| Gross profit | 7,925 | 11,999 | 8,297 | 7,083 |
| Research and development | 765 | 944 | 801 | 824 |
| Professional services | 1,242 | 1,752 | 1,481 | 1,621 |
| Salaries and related costs | 3,253 | 4,667 | 3,191 | 3,072 |
| Selling, general and administrative | 3,576 | 4,625 | 3,656 | 4,140 |
| Total other costs and expenses | 8,836 | 11,988 | 9,129 | 9,657 |
| Gain from operations | -911 | 11 | -832 | -2,574 |
| Other expense, net | - | - | - | 0 |
| Interest income | 244 | 234 | 292 | 278 |
| Interest expense | 1,369 | 1,407 | 1,413 | 1,393 |
| Other income, net | 36 | 16 | 76 | - |
| Total other expense, net | -1,089 | -1,157 | -1,045 | -1,115 |
| Loss before income taxes | -2,000 | -1,146 | -1,877 | -3,689 |
| Income tax expense | 143 | 94 | 78 | 49 |
| Net loss | -2,143 | -1,240 | -1,955 | -3,738 |
| Net loss attributable to non-controlling interest | -35 | 59 | 29 | 40 |
| Net loss attributable to stockholders | -2,108 | -1,299 | -1,984 | -3,778 |
| Basic EPS | -0.05 | -0.031 | -0.05 | -0.09 |
| Basic Average Shares | 43,742,000 | 42,174,000 | 40,748,000 | 40,729,000 |
Apyx Medical Corp (APYX)
Apyx Medical Corp (APYX)